Hindustan Unilever Ltd (HUL) has unveiled a proposed capital expenditure of up to ₹2,000 crore over the next two years to expand manufacturing capacity in premium, high-growth categories, showing a larger tilt towards margin-accretive segments amid evolving consumer demand in India’s FMCG landscape.
The investment will be deployed across multiple locations and will focus on scaling capacity in beauty & wellbeing and home care liquids, segments that are witnessing faster premiumisation and higher value growth compared to mass categories. The move aligns with HUL’s stated strategy of making “fewer, bigger bets” while deepening its presence in spaces such as premium skin care, hair care, and specialised personal and home care formats.
From a strategic standpoint, the proposed capex marks a clear shift towards reinforcing HUL’s premium portfolio at a time when urban consumption is rebounding and consumers are increasingly trading up for differentiated, science-backed, and convenience-led products. Premium categories not only offer stronger pricing power but also help insulate margins in an environment marked by input cost volatility and competitive intensity.
The capacity expansion will be supported by advanced automation and digital technologies, signalling HUL’s intent to build a more agile and responsive supply chain. Enhanced manufacturing flexibility is expected to enable quicker turnaround times, better demand forecasting, and efficient servicing of emerging channels such as e-commerce, quick commerce, and modern trade, formats that are increasingly driving premium FMCG growth.
Equally significant is the sustainability dimension of the investment. The new and expanded facilities will be aligned with HUL’s environmental agenda, with a target to operate on 100% renewable energy. This reinforces the company’s long-term commitment to decarbonisation and resource efficiency, even as it scales operations.
HUL MD &CEO Priya Nair said the move reflects the company’s focus on building future-ready categories and a resilient, technology-enabled supply chain that can consistently deliver superior consumer value.
The manufacturing push comes alongside some recent portfolio actions in the fast-growing health & wellbeing (H&W) segment. HUL had approved the acquisition of the remaining 49% stake in Zywie Ventures Pvt Ltd, the owner of the plant-based nutrition brand OZiva, for ₹824 crore, making it a wholly owned subsidiary. In parallel, HUL decided to divest its 19.8% minority stake in Nutritionalab Pvt Ltd to USV Pvt Ltd for ₹307 crore.
Together, these moves highlight a clear capital allocation strategy: double down on scalable, premium and science-led brands while exiting non-core minority holdings. As consumption patterns shift and competition intensifies, HUL’s investment-led approach positions it to capture long-term growth while strengthening margins and operational resilience.